TN SB1683 | 2023-2024 | 113th General Assembly
Status
Completed Legislative Action
Spectrum: Partisan Bill (Democrat 1-0)
Status: Failed on February 20 2024 - 100% progression
Action: 2024-02-20 - Failed in Senate Commerce and Labor Committee - no second
Text: Latest bill text (Draft #2) [PDF]
Spectrum: Partisan Bill (Democrat 1-0)
Status: Failed on February 20 2024 - 100% progression
Action: 2024-02-20 - Failed in Senate Commerce and Labor Committee - no second
Text: Latest bill text (Draft #2) [PDF]
Summary
As introduced, caps the total amount that a health insurance carrier can require a covered patient with diabetes to pay for a 30-day supply of insulin at no more than $35; caps the total price that a person who supplies prescription insulin drugs into or within this state for use by a patient with diabetes can charge for a 30-day supply of insulin at no more than $35. - Amends TCA Title 8; Title 53; Title 56, Chapter 7; Title 63 and Title 71, Chapter 5.
Title
AN ACT to amend Tennessee Code Annotated, Title 8; Title 53; Title 56, Chapter 7; Title 63 and Title 71, Chapter 5, relative to insulin.
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2024-02-20 | Senate | Failed in Senate Commerce and Labor Committee - no second |
| 2024-02-13 | Senate | Placed on Senate Commerce and Labor Committee calendar for 2/20/2024 |
| 2024-01-11 | Senate | Passed on Second Consideration, refer to Senate Commerce and Labor Committee |
| 2024-01-10 | Senate | Introduced, Passed on First Consideration |
| 2024-01-09 | Senate | Filed for introduction |
Same As/Similar To
HB1737 (Crossfiled) 2024-01-11 - Assigned to s/c Insurance Subcommittee
